A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives



Status:Archived
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2011
End Date:September 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multicenter, Open-label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins


This study is being conducted to evaluate the impact of a 28-day oral contraceptive compared
to two 28-day oral contraceptive regimens containing different synthetic progestins on
ovarian follicular activity and hormone levels in healthy women.



We found this trial at
2
sites
Teva Investigational Site
Seattle, Washington 98105
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Teva Investigational Site
Uniontown, Pennsylvania 15401
?
mi
from
Uniontown, PA
Click here to add this to my saved trials